An interventional study of Mobile App - AmDTx (New name DawnDTx) and Placebo App in Depression Anxiety Disorder and Anxiety and Depression, sponsored by Institute of Mental Health, Singapore. Active, not recruiting at 1 site in Singapore. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-08-21.
Sponsored by Institute of Mental Health, Singapore · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 47 studies in Anxiety Disorders with a site in Singapore — 15 open to participants now, 20 under way, none of them phase 3. Anxiety Disorders · Singapore.
Among the 47 studies in Anxiety Disorders with a site in Singapore, this one is the 19th largest by planned enrollment of the 37 interventional ones that give a count, is one of 6 that started in 2025, is one of 35 with no phase, reaches primary completion later than 6 of the 19 other live ones, and was the 46th registered.
7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.
Browse Anxiety Disorders studies →15 of the 47 studies in Anxiety Disorders with a site in Singapore are open now. Recruiting first, the newest first:
Institute for Human Development and Potential (IHDP), Singapore · Sites in Singapore
Ages 21–75 · Healthy volunteers
National University of Singapore · Sites in Singapore
Ages 21+
Nanyang Technological University · Sites in Singapore
Ages 4–6 · Healthy volunteers
Singapore Management University · Sites in Singapore
Ages 18–30 · Healthy volunteers
KK Women's and Children's Hospital · Sites in Singapore
Ages 21–90
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 944 Anxiety Disorders studies recruiting now, 417 (44%) set no upper age limit and 460 (49%) stop at 75 or younger; 233 take children under 18; 317 take healthy volunteers.
This study: 13 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
47 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 6 started in 2025.
This study's planned enrollment of 122 is above the median of 80 across 6,062 interventional studies indexed under Anxiety Disorders.
Median enrollment 122 across the 37 interventional studies, 600 across the 10 observational. Of the 23 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 47 has an industry lead sponsor. The 10 most frequent:
Institute of Mental Health, Singapore is the lead sponsor of 18 studies on the registry; 9 are open to participants now.
Institute of Mental Health, Singapore has 3 studies filed under Anxiety Disorders — fewer than ten, so there is no comparison to draw.
4 of the studies in Anxiety Disorders with a site in Singapore that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07425951Nanyang Technological UniversityBuilding Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years | 2026-11-30 |
| NCT03408717KK Women's and Children's HospitalEvaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery | 2026-12-31 |
| NCT03415620KK Women's and Children's HospitalPerioperative Music Listening on Anxiety, Pain, Analgesia Use and Patient Satisfaction | 2026-12-31 |
| NCT03685422KK Women's and Children's HospitalPreoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery | 2027-05-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 47 studies in Anxiety Disorders with a site in Singapore, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Randomized Control Trial of AmDTx (new name DawnDTx) on waitlist patients waiting for first psychiatric consultation to determine if a digital mental health app can reduce PHQ8 and GAD7 scores during the waitlist period.
Results from the study will provide information on how IMH/SGH and Mobio Interactive (commercial partner) can best provide enhanced healthcare within the outpatient context on a broader scale. By evaluating the changes in depression and anxiety (amongst other measures) in adults and adolescents who are on a waitlist for services at IMH and SGH and receiving access to AmDTx (compared to placebo control, we can see the effectiveness of such an application in helping patients on future waitlists to decrease their morbidity before they see their clinician in the speciaist clinics of IMH and SGH. The study will enable the investigators to evaluate the treatment acceptability, credibility, and satisfaction of AmDTx and healthcare services at IMH and SGH, as perceived by both patients and clinicians, while patients are waitlisted for services and using AmDTx (compared to placebo control). This will enable us to improve the qualtiy of care at both institutions.
The study will also allow the investigators to evaluate the association between clinical symptom severity and healthcare utilisation with use of AmDTx (compared to placebo control), this will futher guide the future triaging of patients to these healthcare institutions based on their severity of symptoms as detected with the use of the application. This will ensure a more robust and efficient triaging process that caters more to more sevely unwell patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Actual AmDTx App
Other: Mobile App - AmDTx (New name DawnDTx)
Placebo App
Other: Placebo App
Mobile mental health app
Placebo App
GAD7
GAD7
Time frame: 8 weeks
PHQ8
PHQ8
Time frame: 8 weeks
Plan to share: No — Study team can analyze results
No publications or documents are linked to this record.
Ran from Feb 2025 to primary completion in May 2026, 15 months.
Of 3,841 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 15 months is above that.
Counting every sponsor, half of 3,943 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institute of Mental Health, Singapore